Exchange rates help boost Lilly profit-WEB ONLY
Investors and analysts brushed off the 21-percent quarterly profit growth announced by Eli Lilly and Co. this morning and focused on the company’s launch of its new blood-thinning drug Effient. Shares of the Indianapolis-based drugmaker were flat in morning trading, in line with broader markets, even though Lilly boosted its year-end profit forecast by a […]